Full List Of Stories
Europe close: Stocks trim weekly loss, Dax finishes higher
Good news out of a clinical trial for an experimental treatment for the Covid-19 virus in the States helped lift the mood among investors across the Continent and helped to offset a grim set of economic data out of China.
Credit Suisse upgrades Ferguson, expects dividend restart
Credit Suisse upgraded its recommendation for shares of Ferguson and hiked its target price, pointing out the various positives in its equity story and arguing that even under its 'grey sky' scenario, the plumbing and heating products distributor's earnings were set to be more stable than in 2008-09.
Deutsche Bank stays at 'buy' on Vodafone despite 'not great' underperformance
Analysts at Deutsche Bank kept their recommendation for shares of Vodafone at 'buy', despite their underperformance versus the sector and the wider market year-to-date.
RBC Capital labels news on Gilead Science's Remdesivir 'promising on the surface'
Analysts at RBC Capital sounded a positive note on reports published overnight regarding the results of a phase III clinical trial at a Chicago hospital for Gilead Science's Remdesivir drug for treating Covid-19.
Europe midday: Stocks snap back amid optimism for Covid-19 treatment Remdesivir
Good news out of a clinical trial for an experimental treatment for the Covid-19 virus in the States helped lift the mood among investors across the Continent and helped to offset a grim set of economic data out of China.